ProShare Advisors’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $154K | Sell |
|
|||||
|
2025
Q2 | $187K | Buy |
|
|||||
|
2025
Q1 | $172K | Sell |
|
|||||
|
2024
Q4 | $270K | Buy |
|
|||||
|
2024
Q3 | $109K | Buy |
|
|||||
|
2024
Q2 | $62.9K | Sell |
|
|||||
|
2024
Q1 | $95.4K | Buy |
|
|||||
|
2023
Q4 | $160K | Buy |
|
|||||
|
2023
Q3 | $95.8K | Buy |
|
|||||
|
2023
Q2 | $117K | Buy |
|
|||||
|
2023
Q1 | $116K | Sell |
|
|||||
|
2022
Q4 | $142K | Buy |
|
|||||
|
2022
Q3 | $146K | Buy |
|
|||||
|
2022
Q2 | $136K | Sell |
|
|||||
|
2022
Q1 | $251K | Sell |
|
|||||
|
2021
Q4 | $440K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $368K | Buy |
|
|||||
|
2021
Q1 | $234K | Buy |
|
|||||
|
2020
Q4 | $63K | Buy |
|